International trade and protection of intellectual property; TRIPS Waiver; compulsory licensing and other IP issues in multiple countries. Proposals to change corporate tax rates and related laws as part of budget reconciliation process Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding. Advocate on drug pricing proposals, including reconciliation legislation, and expanding access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Engage on pharmaceutical policy as it relates to payments under the 340B program. Highlight Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatments for COVID-19 (2019 Novel Coronavirus), including: manufacturing, clinical trials, reimbursement and coverage of Veklury (remdesivir). Advocate on drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, oncology products, and COVID-19 therapies including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to Notice of Benefit and Payment Parameters (NBPP), hospital inpatient payments, and Value-Based Purchasing arrangements. Funding for Hepatitis C, HIV, and public health activities via appropriations. Drug pricing proposals and budget reconciliation. S.Con.Res.14.
TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404, US
DAVID PULLIAM CHARLES M. CLAPTON MICHAEL D BOYD CHARLES M. CLAPTON DAVID PULLIAM DAVID PULLIAM CHARLES M. CLAPTON JENNIFER NIETO CAREY DAVID PULLIAM CHARLES M. CLAPTON MICHAEL D BOYD ANNA GRIFFIN JENNIFER NIETO CAREY TERESA BILL GRACE RODDEN (Leg. Asst./ Leg. Counsel - Rep. Ann Kirkpatrick; Investigative Counsel - House Comm. on Vet. Affairs; Oversight and Investigations Subcomm. Staff Director and Chief Counsel - House Comm. on Vet. Affairs; Gen. Counsel - House Comm. on Vet. Affairs) DAVID PULLIAM CHARLES M. CLAPTON MICHAEL D BOYD ANNA GRIFFIN JENNIFER NIETO CAREY TERESA BILL GRACE RODDEN (Leg. Asst./ Leg. Counsel - Rep. Ann Kirkpatrick; Investigative Counsel - House Comm. on Vet. Affairs; Oversight and Investigations Subcomm. Staff Director and Chief Counsel - House Comm. on Vet. Affairs; Gen. Counsel - House Comm. on Vet. Affairs) DAVID PULLIAM CHARLES M. CLAPTON JENNIFER NIETO CAREY TERESA BILL GRACE RODDEN (Leg. Asst./ Leg. Counsel - Rep. Ann Kirkpatrick; Investigative Counsel - House Comm. on Vet. Affairs; Oversight and Investigations Subcomm. Staff Director and Chief Counsel - House Comm. on Vet. Affairs; Gen. Counsel - House Comm. on Vet. Affairs)
Leg. Asst./ Leg. Counsel - Rep. Ann Kirkpatrick; Investigative Counsel - House Comm. on Vet. Affairs; Oversight and Investigations Subcomm. Staff Director and Chief Counsel - House Comm. on Vet. Affairs; Gen. Counsel - House Comm. on Vet. Affairs Leg. Asst./ Leg. Counsel - Rep. Ann Kirkpatrick; Investigative Counsel - House Comm. on Vet. Affairs; Oversight and Investigations Subcomm. Staff Director and Chief Counsel - House Comm. on Vet. Affairs; Gen. Counsel - House Comm. on Vet. Affairs Leg. Asst./ Leg. Counsel - Rep. Ann Kirkpatrick; Investigative Counsel - House Comm. on Vet. Affairs; Oversight and Investigations Subcomm. Staff Director and Chief Counsel - House Comm. on Vet. Affairs; Gen. Counsel - House Comm. on Vet. Affairs